Xortx Therapeutics Inc (XRTX) Stock Price, Quote & News

Company Profile

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, w...

Industry: Biotechnology

Sector: Healthcare

Phone: 403 455 7727

Website: www.xortx.com

Address:

3710 – 33rd Street NW, Calgary, Canada

BigTimePennyStocks Jan. 12 at 1:28 AM

Small-Cap with Catalysts this week: 👇👇 ( $AUUD, $XRTX, $OFAL, $LGVN, $ENVB, etc...) #NASDAQ #NYSE

0 · Reply

BillionerOfKing Jan. 2 at 3:19 AM

$XRTX Current Stock Price: $0.56

0 · Reply

warm_it_up Jan. 2 at 12:44 AM

$XRTX https://www.xortx.com/news/press-releases/detail/193/xortx-announces-pioneering-research-on-genome-wide More of this please!

0 · Reply

JohnTrack Jan. 1 at 2:57 AM

$XRTX really good news!! https://www.rapidticker.com/news/xrtx-xortx-announces-pioneering-research-on-286f6c

0 · Reply

honestrick Dec. 31 at 4:15 PM

$SIDU Help a guy out. If everyone just sold 10% and bought $XRTX it will go up in Jan 2026 after the webcast , You will make me very happy . Ok... I can dream . GLTA ...

0 · Reply

honestrick Dec. 29 at 6:33 PM

$XRTX Dont blink .

0 · Reply

warm_it_up Dec. 29 at 2:14 AM

$XRTX I had a dream that I woke up and this was $3. A guy can dream.

0 · Reply

spikespants Dec. 29 at 12:00 AM

$SAFX $AIIO $XRTX strange ambiguous posts from multiple accounts with different names... All of them only have one single post.

0 · Reply

EvolutionExpert Dec. 26 at 12:32 PM

$XRTX The environment increasingly favors disciplined operators instead of aggressive storytellers. Improving execution cadence across quarters would alter sentiment materially. Confidence weakens if progress becomes episodic rather than consistent. Execution quality will determine whether momentum is sustainable.

0 · Reply

Joshimi Dec. 22 at 3:43 PM

$XRTX

0 · Reply

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

Oct 20, 2025, 8:34 PM EDT - 3 months ago

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

Oct 20, 2025, 6:45 PM EDT - 3 months ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Oct 17, 2025, 7:00 AM EDT - 3 months ago

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

Sep 3, 2025, 7:00 AM EDT - 4 months ago

XORTX Initiates IND Preparation for XORLO™ in Gout Program

Aug 8, 2025, 7:54 PM EDT - 5 months ago

XORTX Completes USD $114,500 Private Placement

Jul 22, 2025, 7:59 PM EDT - 6 months ago

XORTX Completes Non-Brokered Private Placement of Units

Jun 26, 2025, 7:00 AM EDT - 7 months ago

XORTX Announces USD $925,000 Private Placement

May 19, 2025, 7:00 AM EDT - 8 months ago

XORTX Announces USD $3 Million Offering

Apr 17, 2025, 7:45 PM EDT - 9 months ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Jan 17, 2025, 5:00 PM EST - 1 year ago

XORTX Announces Change of Auditor

Dec 12, 2024, 9:17 AM EST - 1 year ago

XORTX Announces Presentation at the Rare and Genetic Disease Summit

Oct 18, 2024, 4:00 PM EDT - 1 year ago

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 9, 2024, 5:00 AM EDT - 1 year ago

XORTX Initiates Precision Medicine Program

Sep 13, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Results of Annual and Special Meeting of Shareholders

Sep 12, 2024, 5:30 PM EDT - 1 year ago

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

Sep 6, 2024, 5:30 PM EDT - 1 year ago

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Sep 3, 2024, 12:30 PM EDT - 1 year ago

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

Aug 23, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

Aug 20, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

May 17, 2024, 7:00 AM EDT - 1 year ago

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

Apr 30, 2024, 1:54 PM EDT - 1 year ago

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

Apr 22, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Publication of Key Research in ADPKD

Apr 8, 2024, 7:30 AM EDT - 1 year ago

XORTX Welcomes New Member to the Board of Directors

Mar 27, 2024, 5:00 AM EDT - 1 year ago

XORTX Announces New Clinical Advisory Board Member

Mar 19, 2024, 5:00 AM EDT - 1 year ago

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

Mar 4, 2024, 7:00 AM EST - 2 years ago

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

Feb 1, 2024, 8:46 PM EST - 2 years ago

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

Jan 15, 2024, 7:00 AM EST - 2 years ago

XORTX Announces $2 Million Public Offering

Jan 3, 2024, 7:00 AM EST - 2 years ago

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

Nov 30, 2023, 7:30 AM EST - 2 years ago

XORTX Announces US ATM Offering

Nov 29, 2023, 7:00 AM EST - 2 years ago

XORTX Meets Nasdaq Continued Listing Requirements

Nov 10, 2023, 7:00 AM EST - 2 years ago

XORTX Clarifies Timing for Share Consolidation

Nov 8, 2023, 5:00 PM EST - 2 years ago

XORTX Announces Share Consolidation

Oct 27, 2023, 5:30 PM EDT - 2 years ago

XORTX Announces Results of Special Meeting of Shareholders

Oct 25, 2023, 5:00 PM EDT - 2 years ago

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

Oct 25, 2023, 7:00 AM EDT - 2 years ago

XORTX Announces Rescheduling of Special Meeting of Shareholders

Oct 12, 2023, 7:00 AM EDT - 2 years ago

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

Oct 4, 2023, 7:00 AM EDT - 2 years ago

XORTX Calls Special Meeting of Shareholders

Aug 29, 2023, 7:00 AM EDT - 2 years ago

XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease

Aug 4, 2023, 5:00 PM EDT - 2 years ago

XORTX Appoints Chief Financial Officer

Jun 23, 2023, 8:51 PM EDT - 2 years ago

XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company's Upcoming Annual and Special Meeting of Shareholders

May 24, 2023, 7:00 AM EDT - 2 years ago

XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

Apr 21, 2023, 7:00 AM EDT - 2 years ago

XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

Feb 1, 2023, 7:00 AM EST - 3 years ago

XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease

Jan 19, 2023, 7:00 AM EST - 3 years ago

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

Dec 8, 2022, 7:00 AM EST - 3 years ago

XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Nov 28, 2022, 7:00 AM EST - 3 years ago

XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study

Nov 16, 2022, 7:00 AM EST - 3 years ago

XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer

Nov 3, 2022, 5:00 PM EDT - 3 years ago

XORTX Presents New Proof of Concept Data at American Society of Nephrology

BigTimePennyStocks Jan. 12 at 1:28 AM

Small-Cap with Catalysts this week: 👇👇 ( $AUUD, $XRTX, $OFAL, $LGVN, $ENVB, etc...) #NASDAQ #NYSE

0 · Reply

BillionerOfKing Jan. 2 at 3:19 AM

$XRTX Current Stock Price: $0.56

0 · Reply

warm_it_up Jan. 2 at 12:44 AM

$XRTX https://www.xortx.com/news/press-releases/detail/193/xortx-announces-pioneering-research-on-genome-wide More of this please!

0 · Reply

JohnTrack Jan. 1 at 2:57 AM

$XRTX really good news!! https://www.rapidticker.com/news/xrtx-xortx-announces-pioneering-research-on-286f6c

0 · Reply

honestrick Dec. 31 at 4:15 PM

$SIDU Help a guy out. If everyone just sold 10% and bought $XRTX it will go up in Jan 2026 after the webcast , You will make me very happy . Ok... I can dream . GLTA ...

0 · Reply

honestrick Dec. 29 at 6:33 PM

$XRTX Dont blink .

0 · Reply

warm_it_up Dec. 29 at 2:14 AM

$XRTX I had a dream that I woke up and this was $3. A guy can dream.

0 · Reply

spikespants Dec. 29 at 12:00 AM

$SAFX $AIIO $XRTX strange ambiguous posts from multiple accounts with different names... All of them only have one single post.

0 · Reply

EvolutionExpert Dec. 26 at 12:32 PM

0 · Reply

Joshimi Dec. 22 at 3:43 PM

$XRTX

0 · Reply

honestrick Dec. 14 at 1:43 AM

$XRTX Webinar for $XRTX on Jan21,2026 at 4.15 pm is a good sign. Jan is usually the start of good things for a stock . Looking for a move up and a continue after the webinar .$DRUG $CGC $BB

0 · Reply

LookaLike Dec. 10 at 5:57 PM

$XRTX of you see the timelines of smallcap biotech stock dont take it seriously. 6-12 months mostly means 12-24 months or more

0 · Reply

andysch Dec. 8 at 5:16 PM

$XRTX …this week or next!? Opinions…

0 · Reply

andysch Dec. 4 at 6:40 PM

$XRTX When IND!?

0 · Reply

honestrick Nov. 28 at 4:29 PM

$XRTX If you want my 200,000 shares, you have to try a lot harder. GLTA .

0 · Reply

honestrick Nov. 25 at 3:36 PM

$XRTX test

0 · Reply

warm_it_up Nov. 7 at 12:06 AM

$XRTX just sick what they've done to this after touching $1.40 the other day. The direct offering was good, but at $0.63 was gross too. Someone tell me there's hope! I'll still hold, but I'm not happy.

1 · Reply

honestrick Nov. 5 at 7:17 PM

$XRTX Show us some LOVE .....

0 · Reply

SPYmyQQQ Nov. 3 at 8:05 PM

🎯 Target Hit 🏁 📨 From Oct 31, 2025 💊 $XRTX 💵 Entry: $0.5598 ✅ Exit: $0.6562 💰 P/L: +17.22% 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

honestrick Nov. 3 at 6:40 PM

$XRTX Whats up?

0 · Reply

Drugtrade Nov. 3 at 6:39 PM

$XRTX soo .. is 52 wk low just not gona update to reflect that weird sip to 33 cents?

0 · Reply

warm_it_up Nov. 3 at 5:25 PM

$XRTX Why the F@&! Didn't I sell all at $1.40? I sold some at $1.30 and then thought I was slick buying after hours that night when it got pummeled.

0 · Reply

Market Cap	4.04M
Revenue (ttm)	0.00
Net Income (ttm)	-3.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	8,943
Avg Vol	74,314
Day's Range	N/A - N/A
Shares Out	6.96M
Stochastic %K	64%
Beta	0.49
Analysts	Strong Buy
Price Target	$14.00